Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-10-19
1996-08-06
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 56, 514 61, 536 21, 536118, 536122, A61K 31715, A61K 31725, C08B 3710, C07H 510
Patent
active
055434037
ABSTRACT:
The invention relates to sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type, of which N-sulfate, N-acetate, and hydroxy groups, are replaced by alkoxy, aryloxy, aralkoxy, or O-sulfate groups. The compounds have antithrombotic and smooth muscle cell proliferation inhibiting activities.
REFERENCES:
patent: 3301848 (1967-01-01), Halleck
patent: 4105760 (1978-08-01), Szejtli et al.
patent: 4221907 (1980-09-01), Nair et al.
patent: 4699900 (1987-10-01), Bayol et al.
patent: 4713373 (1987-12-01), Bayol et al.
patent: 4818816 (1989-04-01), Petitou et al.
patent: 4841041 (1989-06-01), Van Boeckel et al.
patent: 5380716 (1995-01-01), Conrad et al.
Petitou Maurice
van Boeckel Constant A. A.
Akzo Nobel nv
Blackstone William M.
Gormley Mary E.
Robinson Douglas W.
Sanofi (S.A.)
LandOfFree
Sulfated glycosaminoglycanoid derivatives of the heparin and hep does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfated glycosaminoglycanoid derivatives of the heparin and hep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfated glycosaminoglycanoid derivatives of the heparin and hep will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191203